
About BioAmp Diagnostics
BioAmp Diagnostics is a Healthcare company based in Berkeley (United States) founded in 2017 by Nicole Tarlton. Developers of diagnostic tests that help to treat patient with a specific antibiotic. BioAmp Diagnostics offers products and services including DETECT Technology. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Assays and Drug Discovery. Its competitors include Lodestone Biomedical, Araceli Biosciences and ThinkSense; 2 of its 3 listed competitors have raised funding.
Company details
BioAmp Diagnostics was founded in 2017 in Berkeley, United States, within the biotechnology sector. Diagnostic tests are created to detect resistance biomarkers directly from patient samples, enabling physicians to select suitable antibiotics initially. Operations focus on improving treatment accuracy through targeted identification, with the company led by co-founder Nicole Tarlton. Services support clinical decision-making in infectious disease management.
- Headquarters Berkeley, United States
- Founders Nicole Tarlton
- SectorsHealthcare
- Website bioampdx.com
- Social LinkedIn X
- Latest Funding Round$243.81K (USD), Grant
Apr 2024
- InvestorsIllumina
& 3 more
Products & Services of BioAmp Diagnostics
BioAmp Diagnostics offers a comprehensive portfolio of products and services, including DETECT Technology.
Rapid chemistry-based system for quick infection detection and antibiotic guidance.
Funding Insights of BioAmp Diagnostics
- Total Rounds 5
- Last Round Grant — $243,806
- Investors Count 4
All 5 funding rounds of BioAmp Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2024 | $243,806 | Grant | – | – | |
| May 2021 | $224,966 | Grant | – | – | |
| May 2020 | $224,996 | Grant | – | – | |
| Apr 2019 | Seed | – | Illumina | – | |
| Jun 2017 | Seed | – | CITRIS Foundry | – |
4 investors in total: 4 institutional.
Investors in BioAmp Diagnostics
BioAmp Diagnostics has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Illumina, National Science Foundation and America’s Seed Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital fund backed by the US Government | seedfund.nsf.gov | Alexandria, United States | ||
Startup accelerator program is backed by University of California. | citrisfoundry.org | Berkeley, United States | ||
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States | |
Developer of technologies for analysis of genetic variation and function | 1993 | illumina.com | San Diego, United States |
Investor details for BioAmp Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of BioAmp Diagnostics
4 people are tracked at BioAmp Diagnostics (3 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Nicole Tarlton | Co-Founder | Leadership |
Tara deBoer, PhD (She/her) | Founder, CEO | Leadership |
Angel Resendez | Head Of Chemistry | Leadership |
Isha Kane | Business Strategy Specialist | Team |
Complete people profiles for BioAmp Diagnostics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of BioAmp Diagnostics
3 dated milestones of BioAmp Diagnostics across 7 years, from founding to its latest funding, stage changes and deals.
- Founded BioAmp Diagnostics is founded.
- Funding First funding round.
- Funding Latest funding round, Grant, of $244K.
Competitors of BioAmp Diagnostics
BioAmp Diagnostics has 3 listed competitors in our database, 2 of them funded. They include Lodestone Biomedical, Araceli Biosciences and ThinkSense.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lodestonebiomedical.com | 2015 | Hanover, United States | $1.19M | Provider of magnetic nanoparticle platform technology for in vivo biomarker monitoring in immuno-oncology | ||
| aracelibio.com | 2020 | United States | $15.95M | Scientific tools for tissue and cell-based biomarker discovery are developed. | ||
| thinksense.com | 2004 | Mclean, United States | Develops sensors for behavioral health data collection and analysis in trials. |
Detailed competitors of BioAmp Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as BioAmp Diagnostics (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about BioAmp Diagnostics
BioAmp Diagnostics was founded in 2017.
BioAmp Diagnostics is headquartered in Berkeley, United States. It is registered at Berkeley, California, United States.
BioAmp Diagnostics was founded in 2017 in Berkeley, United States, within the biotechnology sector. Diagnostic tests are created to detect resistance biomarkers directly from patient samples, enabling physicians to select suitable antibiotics initially. Operations focus on improving treatment accuracy through targeted identification, with the company led by co-founder Nicole Tarlton. Services support clinical decision-making in infectious disease management.
BioAmp Diagnostics's top competitors include Araceli Biosciences, Lodestone Biomedical and ThinkSense.
BioAmp Diagnostics offers DETECT Technology.
BioAmp Diagnostics has 4 investors. Key investors include Illumina, National Science Foundation, America’s Seed Fund, and CITRIS Foundry.